HOME >> BIOLOGY >> NEWS
Scientists identify cells necessary for tumor angiogenesis

NEW YORK, October 31, 2001 - The biology of tumor growth has been a mystery. While it has been known that tumors recruit cells to form new blood vessels - a process called angiogenesis - and that growth factors are necessary to promote this, the origin of the cells that form the early, new blood vessels has been poorly understood. Researchers at Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University have discovered that tumor angiogenesis occurs when precursor cells from the bone marrow are mobilized and recruited by VEGF (vascular endothelial growth factor) stem cells to the tumor blood vessels. Their findings, published in the November issue of Nature Medicine, suggest new targets for cancer therapies and a possible blood test for cancer.

"We hope to be able to apply our findings to cancer patients for diagnostic purposes and for treatment, and are beginning studies to determine the diagnostic potential," said Dr. David Lyden, a Memorial Sloan-Kettering pediatric oncologist and first author of the study. "There are monoclonal antibodies already developed that can recognize and block mobilized blood cells, preventing tumor growth and metastasis. These are also being studied as possible treatment options."

To identify the origin of cells that contributes to tumor angiogenesis, the researchers wanted to determine if there was a role for bone marrow-derived cells in initiating and maintaining a functioning tumor blood vessel. Study co-author Dr. Shahin Rafii, a vascular hematologist-oncologist at Weill Medical College of Cornell University, had shown that bone marrow-derived circulating endothelial precursor (CEP) cells are mobilized from the bone marrow to contribute to angiogenesis in wound healing. They used the findings from an earlier Memorial Sloan-Kettering study by Lyden and co-author, Dr. Robert Benezra published in the October 1999 issue of the journal Nature that demonstrated that two proteins, Id1 and Id3, ar
'"/>

Contact: Joanne Nicholas
nicholaj@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
31-Oct-2001


Page: 1 2 3 4

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Scientists identify cells necessary for tumor angiogenesis

(Date:5/22/2013)... Screening Trial (NLST) investigators also conclude that the ... low-dose computed tomography (LDCT) versus chest X-ray (CXR) ... is achievable at experienced screening centers in the ... to share with their patients about the benefits ... today,s publication in the New England Journal ...
(Date:5/22/2013)... major new effort to educate the public and decision ... clean water that looms ahead in the 21st century. ... current edition of Chemical & Engineering News , ... the world,s largest scientific society. , Bassam Z. Shakhashiri, ... Ph.D., explain that shortages of reliable supplies of fresh ...
(Date:5/22/2013)... potential environmental and human health effects from disposal ... has led scientists to recommend stronger government policies ... (Li-ion) battery materials. That,s the conclusion of a ... Science & Technology . , Oladele A. Ogunseitan ... become mainstays for powering everything from smart phones ...
Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3
(Date:5/23/2013)... SAN MARINO, Calif. , May 23, 2013 ... announces today a strategic alliance with DAK Renewable ... increase the corn oil yield. VG Energy is ... Inc. (OTC Pink: VGLS). VG Energy,s ... pathways to increase the oil yield in plants, ...
(Date:5/23/2013)... BioTrends Research Group, one of the ... biopharmaceutical issues, finds that, unaided, one in five ... that in the past six months, they have ... anticipation of the next generation of HCV treatments—notably ... 6 percent reported that they had begun warehousing ...
(Date:5/23/2013)... BETHESDA, Md. , May 23, 2013 ... a biotechnology company developing DCVax ® personalized immune ... will use its exhibit at this year,s American Society ... to highlight its leadership role in immune ... The ASCO annual meeting is the pre-eminent conference ...
(Date:5/23/2013)...  Verenium Corporation (Nasdaq: VRNM ), a ... commercialization of high-performance enzymes, today announced that ... at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ... Second Annual Marcum LLP Microcap Conference on Thursday, May ... York City.  The presentation is scheduled to begin at ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3
Cached News: